克洛皮多格雷尔在缺血条件下影响骨折愈合
Sebastian Schreiber1, Janine Stutz1, Lukas Keller1
1Department of Trauma, Hand and Reconstructive Surgery, Saarland University, D-66421 Homburg, Germany.
Biomedicines
|September 27, 2025
概括
克洛皮多格雷尔可能会阻碍组织缺血患者的骨折愈合. 这项研究发现,在缺血性条件下用克洛皮多格雷尔治疗小鼠的骨愈合受损,基因表达发生改变.
科学领域:
- 整形外科 整形外科 整形外科
- 药理学 药理学是指药理学的学科.
- 再生医学是一种再生医学.
背景情况:
- 克洛皮多格雷尔经常用于骨折患者的并发症.
- 现有研究表明,克洛皮多格雷尔可以抑制骨质母细胞的增殖和骨的形成.
- 克洛皮多格雷尔对缺血条件下的骨折愈合的影响尚不清楚.
研究的目的:
- 在肢体缺血的小鼠模型中研究克洛皮多格雷尔对骨折愈合的影响.
- 评估克洛皮多格雷尔是否会影响血液供应受损的骨愈合.
主要方法:
- 建立了一个带有诱导肢体缺血的股骨骨折的小鼠模型.
- 动物每天口服克洛皮多格雷尔 (3毫克/公斤) 或载体.
- 在骨折后2周和5周使用生物力学测试,放射学,组织形态测量和西部斑分析来评估骨愈合.
主要成果:
- 与对照人群相比,克洛皮多格雷尔治疗没有改善骨折的股骨生物力学度.
- 组织形态测量分析显示,克洛皮多格雷尔治疗小鼠的骨折骨中骨架减少,结缔组织增加.
- 西方斑点分析显示,克洛皮多格雷尔组的骨形态遗传蛋白-4 (BMP-4) 的表达减少,CD31的表达增加.
结论:
- 在缺血的情况下,克洛皮多格雷尔会阻碍骨折愈合.
- 这种损伤与血管性 (CD31) 和骨质性 (BMP-4) 标志物的表达变化有关.
- 在骨折患者经历组织缺血时,使用克洛皮多格雷尔可能是禁忌的.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:22Formation of the Platelet Plug
8.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.7K
01:27Peripheral Artery Disease III: Interprofessional Care
245
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
245
01:16Clot Retraction and Fibrinolysis
8.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.5K
01:30Peripheral Artery Disease I: Introduction
314
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
314
01:27Fractures: Bone Repair
5.1K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
5.1K